Investor Tips New vaccine entrant gets approval before Novavax, while herd immunity ideas put sales in doubt. Articles You May Like Stocks making the biggest moves before the bell: Alibaba, Lyft, Walgreens and more Deutsche Bank shares slide after sudden spike in the cost of insuring against its default Social Security trust funds depletion date moves one year earlier to 2034, Treasury says Why you may be subsidizing a coworker’s 401(k) fees Mortgage demand gets a boost from bank volatility, but it may be short-lived
